Our Mission

Create a tomorrow

where vaccine-preventable diseases

are actually prevented.

Our Science

ImmuNovX Biotech is a start-up antigen
manufacturing company focused on developing our proprietary platform technology Antig3NX®, that powers rapid, large-scale production of antigens for use in a novel class of vaccines against pathogens that contain DNA.

Partnering

ImmuNovX is actively seeking partners and collaborators, and would value the opportunity to discuss potential synergies.

ImmuNovX® Biotech
116 Research Drive, Suite 2226
Bethlehem, PA 18015
610-941-4750